Hints and tips:
...said Reddy. “This government treats everything as a public relations issue, not a public health issue.”...
...Corporate earnings: Companies set to report include Indian pharmaceuticals company Dr Reddy’s Laboratories, tech platform Grab and Chinese electronics manufacturer Xiaomi....
...Dr Will Welfare, UKHSA’s public health incident director, said: “As a result of our investigation, we are working with NHS Test and Trace and the company to determine the laboratory technical issues which...
...The research park’s own website says Alder is “a research laboratory focused on mycelium”....
...And, this year, US pharma giant Merck has signed voluntary licensing agreements with eight Indian companies, including Cipla, Dr Reddy’s Laboratories, Hetero and Sun Pharma, to make molnupiravir, an antiviral...
...The first dose of the Sputnik V vaccine was administered in India on Friday, as the country battles a second wave of the pandemic and continues to report record high deaths.Dr Reddy’s Laboratories, which...
...Until then, Dr Reddy's Laboratories, an Indian drugmaker, aims to import Sputnik doses into India once pricing issues are resolved....
...Last February, the group sold some of its branded generics business, which makes drugs that have come off patent, for Rs18.5bn to Dr Reddy’s Laboratories, one of India’s leading pharma groups....
...Jan 21 The US reports the first laboratory-confirmed case as the virus starts to spread beyond mainland China....
...The company said a federal appeals court had denied its motion for a rehearing of its case against Dr Reddy’s Laboratories, after the court decided in November to vacate a preliminary injunction against...
...Shares closed down 47 per cent at an all-time low on Tuesday after Indivior said the US federal court of appeals had vacated a temporary injunction against Dr Reddy’s Laboratories, which makes a generic...
...A US federal appeals court this month denied Indivior’s motion for a rehearing of its case against Dr Reddy’s Laboratories, following a court decision in November to vacate a preliminary injunction that...
...Indivior shares dropped after the US chief justice threw out its challenge to a ruling that Dr Reddy’s Laboratories could start selling generic versions of the company’s blockbuster opiate addiction treatment...
...The company has been locked in a court battle with Dr Reddy’s Laboratories over the rollout in the US of the rival drugmaker’s generic version of Indivior’s top opioid addiction treatment Suboxone Film....
...The US Food and Drug Administration approved two generic versions — from Mylan and Dr. Reddy’s Laboratories — in June 2018....
...Indivior has struggled to retain US market share since rival Dr Reddy’s Laboratories developed a generic alternative to its opioid addiction treatment Suboxone film....
...An appeal lodged by Dr Reddy Laboratories against a US court judgment blocking the sale of its generic version was unlikely to win, Jefferies argued....
...The broker expected Indivior to defeat an appeal lodged by Dr Reddy Laboratories against a US court judgment that had prevented it selling of a generic version of the UK group’s most valuable drug....
...Indivior has struggled to retain US market share in recent months, after rival firm Dr Reddy’s Laboratories developed a generic alternative to its opioid addiction treatment Suboxone film....
...The UK pharmaceuticals company said it was now “seeing the impact” of a generic rival to its opioid addiction treatment Suboxone Film, sold in the US by Indian group Dr Reddy’s Laboratories, which it is...
...London-listed Indivior said the US Court of Appeals had granted rival Dr Reddy Laboratories’ motion to expedite its appeal against a temporary injunction, won by Indivior in July, that bans the sale or import...
...Among the problems is the launch of a generic rival by India’s Dr Reddy’s Laboratories, which it noted it was seeking to block through the courts....
...Reddy’s Laboratories....
...An oral film dosage of Suboxone is under threat by a generic substitute from Dr Reddy’s of India....
International Edition